NONSMALL CELL LUNG CANCER

Clinical trials for NONSMALL CELL LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new NONSMALL CELL LUNG CANCER trials appear

Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 4 Completed 4 Terminated 1

First-in-Class cancer drug targets Hard-to-Treat tumors

Disease control Not yet recruiting

This study tests an experimental oral drug called VMD-102 in people with advanced solid tumors, including liver, lung, kidney, skin (uveal melanoma), and colorectal cancers that have not responded to standard treatments. The drug works by blocking a specific protein (PKC epsilon)…

Matched conditions: NONSMALL CELL LUNG CANCER

Phase: PHASE1, PHASE2 • Sponsor: VM Discovery, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

NONSMALL CELL LUNG CANCER

Get alerted when new NONSMALL CELL LUNG CANCER trials appear

First-in-Class cancer drug targets Hard-to-Treat tumors